INMB INmune Bio Forecast, Technical & Fundamental Analysis

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Get AI intraday signals

INMB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For INMB
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

INMB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For INMB
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

INMB is expected to report earnings to rise 4.68% to -52 cents per share on October 30

Q3'24

Est.

$-0.52

Q2'24

Beat

by $0.13

Q1'24

Missed

by $0.08

Q4'23

Missed

by $0.04

Q3'23

Missed

by $0.08

The last earnings report on August 01 showed earnings per share of -50 cents, beating the estimate of -62 cents. With 298.50K shares outstanding, the current market capitalization sits at 103.52M.

A.I. Advisor

published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 NE Mizner Boulevard

Phone

+1 858 964-3720

Employees

Web

https://www.inmunebio.com

Interesting Tickers

ETFs / NAME	Price $	Chg $	Chg %
		1 Day
SPY	577.99	-5.33	-0.91%
SPDR® S&P 500® ETF Trust
BTC.X	66432.195000	-929.210940	-1.38%
Bitcoin cryptocurrency
GME	20.54	-0.39	-1.86%
GameStop Corp
TSLA	213.65	-4.32	-1.98%
Tesla
AAPL	230.76	-5.10	-2.16%
Apple

INMB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with MDGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then MDGL could also see price increases.

Ticker / NAME	Correlation To INMB	1D Price Change %
INMB	100%	-2.72%
MDGL - INMB	41% Loosely correlated	-0.55%
ORMP - INMB	38% Loosely correlated	+0.42%
AXON - INMB	37% Loosely correlated	-1.54%
CYTK - INMB	34% Loosely correlated	-3.46%
PRME - INMB	32% Poorly correlated	-10.54%
More